Butyltolylquinuclidine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 20:15, 25 December 2013 (Drugbox additions). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Butyltolylquinuclidine
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: legal
Identifiers
  • (2R,3S,4S)-2-butyl-3-p-tolylquinuclidine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H27N
Molar mass257.414 g/mol g·mol−1
3D model (JSmol)
  • C3CC1CCN3C(CCCC)C1c(cc2)ccc2C
  • InChI=1S/C18H27N/c1-3-4-5-17-18(15-8-6-14(2)7-9-15)16-10-12-19(17)13-11-16/h6-9,16-18H,3-5,10-13H2,1-2H3
  • Key:QYIZEJQSBLRXJK-UHFFFAOYSA-N
  (verify)

2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI.[1] It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse,[2] and produces similar effects to cocaine in animal studies, although milder and longer lasting.

References

  1. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12614900, please use {{cite journal}} with |pmid=12614900 instead.
  2. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12565962, please use {{cite journal}} with |pmid=12565962 instead.